Pfizer, Governor Offer Good News
Photo Credit: Office of Governor Ned Lamont
On July 22, I had the privilege to be invited when Pfizer announced the significant progress they have made on a vaccine for COVID-19. Groton Site Director and Senior Vice President John Burkhardt shared that the promising candidate is on track to enter expanded safety and efficacy trials at the end of July with regulatory review possible as early as October 2020. The U.S. government placed an initial order of 100 million doses, which could be available by the end of the year on this timeline. Once manufacturing is rolling, 1.3 billion doses are possible by the end of 2021. Recent news includes a similar contract to supply 120 million doses of vaccine to Japan in the first half of 2021.
It was heartening to hear such positive news, particularly stemming from the hard work and dedication of our friends and neighbors who work in many capacities at Pfizer. The global team they are a part of offers hope during one of the world’s greatest challenges. I would just like to extend the thanks of a grateful community.
The good news included an update from Governor Lamont. Connecticut has significantly curtailed the number of new infections. Pulling together and following safety measures is paying off, and keeping the infection rates low will allow the state to resume more of our normal business and activities.
During these difficult times and in face of loses suffered by many, good news is welcome. Good news that comes from the strength, innovation, and dedication of our community is the best news of all.